Ascorbic acid for treatment of CMT1A: the jury is still out
- PMID: 19427270
- DOI: 10.1016/S1474-4422(09)70112-7
Ascorbic acid for treatment of CMT1A: the jury is still out
Comment on
-
Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial.Lancet Neurol. 2009 Jun;8(6):537-44. doi: 10.1016/S1474-4422(09)70108-5. Epub 2009 May 6. Lancet Neurol. 2009. PMID: 19427269 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
